MEDNAX Inc. ( MD) Q3 2011 Earnings Conference Call November 1, 2011 10:00 AM ET Executives David Parker – VP, IR Roger Medel – Director and CEO Vivian Lopez-Blanco – CFO Karl Wagner – President, American Anesthesiology Analysts Brian Zimmerman – Deutsche Bank Joanna Gajuk – Bank of America Ryan Daniels – William Blair Bill Bonello – RBC Capital Markets Robert Mains – Morgan Keegan Ralph Giacobbe – Credit Suisse Kevin Ellich – Piper Jaffray Brooks O'Neill – Dougherty & Company Matt Weight – Feltl & Company PresentationOperator
Ladies and gentlemen, thank you for standing by. Welcome to the MEDNAX 2011 third quarter earnings call. For the conference all the participants are in a listen-only mode. There will be an opportunity for your questions instructions will be given at that time (Operator Instructions) and as a reminder, this call is being recorded. Now that been said, I'll turn the conference now to the Vice President of Investor Relations Mr. David Parker. Please go ahead. David Parker Thank you, John and good morning everyone. Certain statements and information presenting during this conference call may contain forward-looking statements. These forward-looking statements are based on assumptions and assessments made by MEDNAX's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today, and MEDNAX undertakes no duty to update or revise any such statements whether as a result of new information, future events or otherwise. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the company's most recent annual report on Form 10-K, including the sections entitled Risk Factors, which is available on the Investors page of our website, www.mednax.com.